T-Cypher Bio Presents Promising Data on Two T Cell Engager Development Candidates for High Copy Number Cancer Targets at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Preclinical data to be presented on two T cell engager development candidates targeting high copy number HLA-A*02 bound peptides in solid tumors with high unmet need including NSCLC, HNSCC, GI cancers, and melanoma.